(Q44856581)

6 December 2017

title

Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy (English)

1 reference

6 December 2017

1 reference

Keisuke Kawai

1

1 reference

6 December 2017

Fuzhong Qin

2

1 reference

6 December 2017

Junya Shite

3

1 reference

6 December 2017

Weike Mao

4

1 reference

6 December 2017

Shuji Fukuoka

5

1 reference

6 December 2017

Chang-Seng Liang

6

1 reference

6 December 2017

publication date

22 April 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

6 December 2017

published in

1 reference

6 December 2017

volume

287

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

H1003-12

1 reference

Structural basis of end-stage failure in ischemic cardiomyopathy in humans

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Heart failure, oxidative stress, and ion channel modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Myocyte apoptosis: programming ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Carvedilol decreases elevated oxidative stress in human failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

The pharmacology of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Cardioprotection by Carvedilol: Antiapoptosis is Independent of β-Adrenoceptor Blockage in the Rat Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Oxidative stress in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Apoptosis in pressure overload-induced heart hypertrophy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Detection of apoptotic cells in human colorectal cancer by two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

A mechanistic role for cardiac myocyte apoptosis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00797.2003

10.1152/AJPHEART.00797.2003

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference